Clinical trials: Corneal Epithelial Degeneration
- Condition Corneal Epithelial Degeneration
- Funder type Industry (pharma, biotech, devices)
- Accepts healthy volunteers yes
Corneal Epithelial Degeneration
Dose Escalation TTHX1114 Ophthalmic Solution
Dose escalation 3+3 design with accelerated titration 4 dose levels
- Trial name
- EPI (NCT05769920)
- Testing
- TTHX1114(NM141) Ophthalmic Solution
- Where
- United States
- Volunteers
- 8 people, healthy volunteers welcome
- Sponsor
- Trefoil Therapeutics, Inc.